Oral	JJ	O
polio	NN	O
vaccines	NNS	O
were	VBD	O
developed	VBN	O
by	IN	O
several	JJ	O
groups	NNS	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
was	VBD	O
led	VBN	O
by	IN	O
Albert	NNP	O
Sabin	NNP	O
.	.	O

Other	JJ	O
groups	NNS	O
,	,	O
led	VBN	O
by	IN	O
Hilary	NNP	O
Koprowski	NNP	O
and	CC	O
H.R.	NNP	O
Cox	NNP	O
,	,	O
developed	VBD	O
their	PRP$	O
own	JJ	O
attenuated	JJ	O
vaccine	NN	O
strains	NNS	O
.	.	O

The	DT	O
various	JJ	O
vaccines	NNS	O
were	VBD	O
carefully	RB	O
evaluated	VBN	O
for	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
induce	VB	O
immunity	NN	O
to	IN	O
polio	NN	O
,	,	O
while	IN	O
retaining	VBG	O
a	DT	O
low	JJ	O
incidence	NN	O
of	IN	O
neuropathogenicity	NN	O
in	IN	O
monkeys	NNS	O
.	.	O

Based	VBN	O
on	IN	O
these	DT	O
results	NNS	O
,	,	O
the	DT	O
Sabin	NNP	O
strains	NNS	O
were	VBD	O
chosen	VBN	O
for	IN	O
worldwide	JJ	O
distribution	NN	O
.	.	O

